この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/4/171 分で読めます
Withdrawal of Approval of Part of a New Animal Drug Application; Tiamulin
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of those parts of a new animal drug application (NADA) for a tiamulin Type A medicated article that pertain to the production indications for use of increased rate of weight gain and improved feed efficiency in swine. This action is being taken at the sponsor's request because this product is no longer marketed for these uses.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →